Viewing StudyNCT00464893



Ignite Creation Date: 2024-05-05 @ 5:28 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00464893
Status: COMPLETED
Last Update Posted: 2013-12-04
First Post: 2007-04-23

Brief Title: Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
Sponsor: Neovii Biotech
Organization: Neovii Biotech

Conditions & Keywords Data

Conditions:
Name
Gastric Adenocarcinoma
Gastric Cancer
Keywords:
Name View
gastric cancer View
catumaxomab View
neoadjuvant chemotherapy View
phase II View
interoperative View
trifunctional antibody View